Loading...
01/11 03:34
Loading...
Access earnings results, analyst expectations, report, slides, earnings call, and transcript.
The earnings call summary reveals several negative factors: the company is operating below its RBC target range, faces risks with a reinsurance agreement, and has lower-than-expected investment returns. Despite share repurchases, financial metrics are weak with declining earnings. Management's vague responses in the Q&A add uncertainty. While there are positive aspects like increased life insurance sales, the overall sentiment is negative, especially given the market cap of $2.7 billion, which suggests a moderate reaction to these developments.
Total Adjusted Capital (TAC) $5.7 billion (up $300 million from $5.4 billion at the end of Q2 2024) due to efforts to simplify the VA and Shield hedging program.
Combined Risk-Based Capital (RBC) Ratio Estimated between 365% and 385% at the end of Q3 2024, down from the target range of 400% to 450% due to a normalized statutory loss of approximately $300 million and changes in the interest rate environment.
Adjusted Earnings $243 million (down from $275 million in Q3 2023 and $346 million in Q2 2024) due to lower alternative investment returns and a normalized statutory loss.
Annuities Segment Adjusted Earnings $307 million (excluding notable items), reflecting lower fees driven by seasonality.
Life Segment Adjusted Earnings $41 million (excluding notable items), with lower net investment income offset by a higher underwriting margin.
Runoff Segment Adjusted Loss $107 million (excluding notable items), reflecting lower net investment income and a lower underwriting margin.
Corporate Expenses $203 million in Q3 2024 (down 5% year-over-year), with expectations for an increase in Q4 due to seasonality.
Common Stock Repurchase $64 million in Q3 2024, totaling over $2.4 billion since the program began in August 2018, reducing shares outstanding by over 50%.
Total Annuity Sales $7.8 billion year-to-date (consistent with the same period in 2023), with Shield Annuity products at $5.8 billion, a 15% increase over 2023.
Life Insurance Sales $87 million year-to-date (up 19% compared to the same period last year).
New Shield Product Launch: Launched a new Shield product in July, expanding hedging strategy to include Shield Level Pay+ product in Q4.
LifePath Paycheck Product Launch: Expanded into the institutional space with the launch of BlackRock's LifePath Paycheck product.
Annuity Sales Growth: Total annuity sales were $7.8 billion year-to-date, consistent with 2023; Shield Annuity sales increased by 15% to $5.8 billion.
Life Insurance Sales Growth: Life insurance sales increased by 19% year-to-date to $87 million.
Corporate Expense Management: Corporate expenses decreased by 5% year-over-year to $203 million in Q3.
Share Repurchase Program: Repurchased $64 million of common stock in Q3, totaling over $2.4 billion since August 2018.
Reinsurance Agreement: Final stages of a reinsurance agreement for a legacy block of fixed and payout annuities expected to close before year-end.
Hedging Strategy Simplification: Simplifying hedging strategy for variable annuities and Shield products to improve capital efficiency.
Risk-Based Capital (RBC) Ratio: The company is currently operating below its targeted RBC range of 400% to 450%, estimating a ratio between 365% and 385%. This is due to strategic initiatives and a normalized statutory loss of approximately $300 million in the quarter.
Reinsurance Agreement: Brighthouse is in the final stages of a reinsurance agreement for a legacy block of fixed and payout annuities, which is expected to improve the RBC ratio. However, the timing and execution of this agreement pose a risk.
Hedging Strategy Complexity: The complexity of managing the variable annuity and Shield business has increased, necessitating a revised hedging strategy. While efforts are underway to simplify this, the transition carries inherent risks.
Interest Rate Environment: The company experienced a modest loss associated with significant changes in the interest rate environment, which could impact future earnings and capital requirements.
New Business Strain: There is a continuation of negative impacts from new business strain, which is expected to lessen in future quarters as the company implements its new hedging strategies.
Alternative Investment Returns: The alternative investment yield was lower than expected at 1.6%, compared to a long-term expectation of 9% to 11%, which could affect overall financial performance.
Expense Management: While corporate expenses have decreased, an anticipated increase in the fourth quarter due to seasonality presents a challenge to maintaining cost efficiency.
Strategic Initiatives: Brighthouse Financial is focused on improving capital efficiency and unlocking capital to return the combined risk-based capital (RBC) ratio to the target range of 400% to 450% in normal market conditions. Key initiatives include reinsurance opportunities and simplifying the hedging strategy.
Reinsurance Agreement: The company is in the final stages of a reinsurance agreement for a legacy block of fixed and payout annuities, expected to close before year-end, which would positively impact the RBC ratio.
Hedging Strategy: Brighthouse is simplifying its hedging strategy by hedging Shield sales on a stand-alone basis and developing a revised strategy for the in-force book.
Sales Growth: The company reported strong sales results, with total annuity sales of $7.8 billion year-to-date, including a 15% increase in Shield Annuity products.
Life Insurance Sales: Life insurance sales increased by 19% year-to-date, totaling $87 million.
Institutional Product Launch: The launch of BlackRock's LifePath Paycheck product is expected to generate additional inflows in 2025.
RBC Ratio Guidance: The estimated combined RBC ratio at the end of Q3 was between 365% and 385%. Pro forma for the pending reinsurance transaction, it is expected to be at the lower end of the target range of 400% to 450%.
Corporate Expenses Guidance: Full year 2024 corporate expenses are anticipated to be lower than 2023, despite an expected increase in Q4 due to seasonality.
Adjusted Earnings Guidance: Adjusted earnings for Q3 were $243 million, with expectations for future quarters to improve as new business strain decreases.
Alternative Investment Returns: The company expects long-term returns of 9% to 11% annually for its alternative investment portfolio.
Share Repurchase Program: In the third quarter, Brighthouse Financial repurchased $64 million of its common stock, with an additional approximately $25 million repurchased through November 1. Since the start of the share repurchase program in August 2018, the company has repurchased over $2.4 billion of its common stock, reducing shares outstanding by over 50%.
The earnings call summary indicates several negative factors: slowed Shield sales due to competition, unclear responses on buybacks and cash flow issues, and heightened claims severity. Although management expressed confidence in their capabilities, the lack of quantitative guidance and avoidance of certain questions suggest underlying uncertainties. The market may react negatively due to these ambiguities and potential risks.
The earnings call summary reveals several negative factors: the company is operating below its RBC target range, faces risks with a reinsurance agreement, and has lower-than-expected investment returns. Despite share repurchases, financial metrics are weak with declining earnings. Management's vague responses in the Q&A add uncertainty. While there are positive aspects like increased life insurance sales, the overall sentiment is negative, especially given the market cap of $2.7 billion, which suggests a moderate reaction to these developments.
All transcripts are sourced directly from the official live webcast or the company’s official investor relations website. We use the exact words spoken during the call with no paraphrasing of the core discussion.
Full verbatim transcripts are typically published within 4–12 hours after the call ends. Same-day availability is guaranteed for all S&P 500 and most mid-cap companies.
No material content is ever changed or summarized in the “Full Transcript” section. We only correct obvious spoken typos (e.g., “um”, “ah”, repeated 10 times”, or clear misspoken ticker symbols) and add speaker names/titles for readability. Every substantive sentence remains 100% as spoken.
When audio quality is poor or multiple speakers talk over each other, we mark the section instead of guessing. This ensures complete accuracy rather than introducing potential errors.
They are generated by a specialized financial-language model trained exclusively on 15+ years of earnings transcripts. The model extracts financial figures, guidance, and tone with 97%+ accuracy and is regularly validated against human analysts. The full raw transcript always remains available for verification.
